| 1. |
Giuliante F, Ardito F, Guglielmi A, et al. Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis. JAMA Surg, 2016, 151(10): 916-922.
|
| 2. |
Aoba T, Ebata T, Yokoyama Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg, 2013, 257(4): 718-725.
|
| 3. |
Ebata T, Kosuge T, Hirano S, et al. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg, 2014, 101(2): 79-88.
|
| 4. |
Lykke J, Jess P, Roikjaer O, et al. Increased lymph node yield is associated with improved survival in rectal cancer irrespective of neoadjuvant treatment: results from a National Cohort Study. Dis Colon Rectum, 2015, 58(9): 823-830.
|
| 5. |
Yokota T, Ishiyama S, Saito T, et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol, 2004, 39(4): 380-384.
|
| 6. |
Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg, 2010, 251(4): 675-681.
|
| 7. |
Hakeem AR, Marangoni G, Chapman SJ, et al. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastroenterol Hepatol, 2014, 26(9): 1047-1054.
|
| 8. |
Stephen E, David B, Carolyn C, et al. AJCC Cancer Staging Manual 7ed. New York: Springer, 2010.
|
| 9. |
Kambakamba P, Linecker M, Slankamenac K, et al. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review. Am J Surg, 2015, 210(4): 694-701.
|
| 10. |
Stephen E, Frederick G, David B, et al. AJCC Cancer Staging Manual. 8 ed. New York: Springer, 2017.
|
| 11. |
Nari GA, Palacios OG, Lopez-Ben S, et al. Hilar cholangiocarcinoma: The number of positive nodes and positive node/total node ratio is a significant prognostic factor for survival. Cir Esp, 2014, 92(4): 247-253.
|
| 12. |
Bagante F, Tran T, Spolverato G, et al. Perihilar cholan-giocarcinoma: number of nodes examined and optimal lymph node prognostic scheme. J Am Coll Surg, 2016, 222(5): 750-759.
|
| 13. |
Guglielmi A, Ruzzenente A, Campagnaro T, et al. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford), 2011, 13(4): 240-245.
|
| 14. |
Conci S, Ruzzenente A, Sandri M, et al. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes. Eur J Surg Oncol, 2017, 43(4): 743-750.
|
| 15. |
Kim Y, Spolverato G, Amini N, et al. Surgical management of intrahepatic cholangiocarcinoma: defining an optimal prognostic lymph node stratification schema. Ann Surg Oncol, 2015, 22(8): 2772-2778.
|
| 16. |
Chen LJ, Chung KP, Chang YJ, et al. Ratio and log odds of positive lymph nodes in breast cancer patients with mastectomy. Surg Oncol, 2015, 24(3): 239-247.
|
| 17. |
Aurello P, Petrucciani N, Nigri GR, et al. Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma? J Gastrointest Surg, 2014, 18(7): 1254-1260.
|
| 18. |
Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg, 2001, 233(3): 385-392.
|
| 19. |
Mantel HT, Wiggers JK, Verheij J, et al. Lymph node micrometastases are associated with worse survival in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg Oncol, 2015, 22(Suppl 3): S1107-S1115.
|
| 20. |
Ma WJ, Wu ZR, Hu HJ, et al. Extended lymphadenectomy versus regional lymphadenectomy in resectable hilar cholangiocarcinoma. J Gastrointest Surg, 2019 May 30. doi: 10.1007/s11605-019-04244-7.
|
| 21. |
He M, Xu X, Feng H, et al. Regional lymphadenectomy vs. extended lymphadenectomy for hilar cholangiocarcinoma (Relay-HC trial): study protocol for a prospective, multicenter, randomized controlled trial. Trials, 2019, 20(1): 528.
|
1/5
WeChat